Shares of Avinger Inc. (NASDAQ:AVGR) dropped 1.7% during mid-day trading on Wednesday . The stock traded as low as $6.23 and last traded at $6.26, with a volume of 104,097 shares trading hands. The stock had previously closed at $6.37.

A number of analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of Avinger from a “sell” rating to a “hold” rating in a research report on Friday, July 1st. BTIG Research restated a “buy” rating and set a $18.00 price objective on shares of Avinger in a research report on Friday, July 15th. Finally, Canaccord Genuity restated a “buy” rating on shares of Avinger in a research report on Tuesday, July 12th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. Avinger presently has an average rating of “Hold” and an average price target of $18.75.

The firm’s market cap is $79.97 million. The firm has a 50 day moving average price of $10.65 and a 200-day moving average price of $12.57.

Avinger (NASDAQ:AVGR) last released its quarterly earnings data on Wednesday, May 4th. The medical device company reported ($1.28) earnings per share for the quarter, missing the consensus estimate of ($1.17) by $0.11. Analysts forecast that Avinger Inc. will post ($4.23) EPS for the current fiscal year.

In other news, Director Donald A. Lucas sold 9,309 shares of the firm’s stock in a transaction dated Friday, May 6th. The stock was sold at an average price of $12.58, for a total transaction of $117,107.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Himanshu Patel sold 10,000 shares of the firm’s stock in a transaction dated Friday, May 6th. The stock was sold at an average price of $13.40, for a total value of $134,000.00. Following the transaction, the insider now owns 87,220 shares of the company’s stock, valued at $1,168,748. The disclosure for this sale can be found here.

An institutional investor recently bought a new position in Avinger stock. Thornburg Investment Management Inc. bought a new stake in shares of Avinger Inc. (NASDAQ:AVGR) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 52,792 shares of the medical device company’s stock, valued at approximately $1,199,000. Thornburg Investment Management Inc. owned about 0.42% of Avinger as of its most recent filing with the SEC.

Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses to introduce products based on its lumivascular platform, which is an intravascular image-guided system.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.